Back to all initiatives
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Since June 2018 Europe has the most extensive database of chemical safety information in the world: 96,800 registrations were submitted by chemical companies for nearly 22,600 substances. 775 Belgian chemical companies are accountable for 7168 (7%) registrations for nearly 3654 (16%) substances. But the work is not finished. Companies continue to work hard to implement and improve the safe use of chemicals and to protect human health and the environment. Upon new scientific information, changing technical requirements or decisions made on when and how some type of data and information may be used in registration dossiers, companies continue to update their registration dossiers.

Concerns have been expressed about the quality of some of the REACH registration dossiers. That’s why Cefic and ECHA signed in June 2018 a Memorandum of Understanding as a shared commitment from both industry and ECHA to focus on improving the scientific assessment of some substances or groups of substances, further enhancing safety information and its communication across the supply chain. They agreed to work jointly to solve scientific and technical challenges by facilitating technical discussions between experts and by improving the transparency on the quality of dossiers. In June 2019, Cefic additionally launched an Action Plan to help REACH registrants review chemical safety data.

The CEFIC Action Plan provides a framework for companies – holders of REACH registrations – to evaluate their safety data already submitted under REACH. By using a set of guiding principles laid down in the Action Plan, companies can decide whether their dossiers may need to be updated with additional information in line with the expectations of the European Chemicals Agency (ECHA). The action plan focuses primarily on high-volume substances with potential for wide-spread use, which were registered by the 2010 and 2013 deadlines. The action plan also recommends to pay particular attention to carcinogenicity, prenatal developmental toxicity and reproductive toxicity. For more information about the other guiding criteria, please consult the following page:

essenscia and its member companies actively collaborate to the CEFIC Action Plan for dossier improvement.